Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ROBBY AYOUB

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1396958237
CMS profile
108533
Location
HUNTINGTON BEACH, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$3,981.23

168 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,914.23 167
Education $67.00 1

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 168 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ROBBY AYOUB

NPI 1396958237 · CMS profile ID 108533

Allopathic & Osteopathic Physicians / Internal Medicine / Pulmonary Disease

HUNTINGTON BEACH, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 168 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1396958237?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ROBBY AYOUB, NPI 1396958237, CMS profile ID 108533. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 168 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1396958237?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). ROBBY AYOUB, NPI 1396958237, CMS profile ID 108533. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 168 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1396958237?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
ROBBY AYOUB, NPI 1396958237, CMS profile ID 108533, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 168 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1396958237?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

168 matching records · $3,981.23 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 168 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 168.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme LLC $28.1809/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238268456 CMS
Grifols USA, LLC $30.4509/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249568153 CMS
Verona Pharma, Inc. $22.4309/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233795328 CMS
GlaxoSmithKline, LLC. $28.6909/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190665327 CMS
Insmed, Inc. $20.5709/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186270792 CMS
Viatris Specialty LLC $16.4409/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238465255 CMS
Electromed, Inc. $16.1909/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224593038 CMS
GlaxoSmithKline, LLC. $32.7209/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190705803 CMS
AstraZeneca Pharmaceuticals LP $20.8209/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206260130 CMS
AstraZeneca Pharmaceuticals LP $13.6809/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206280410 CMS
Verona Pharma, Inc. $24.9009/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233795330 CMS
Avadel CNS Pharmaceuticals, LLC $26.8609/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208531589 CMS
Grifols USA, LLC $8.7108/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249568181 CMS
Grifols USA, LLC $10.4408/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249568183 CMS
GlaxoSmithKline, LLC. $29.8708/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191556692 CMS
GlaxoSmithKline, LLC. $30.6408/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190744279 CMS
Novo Nordisk Inc $31.1108/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188409110 CMS
AstraZeneca Pharmaceuticals LP $24.8708/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206396596 CMS
Verona Pharma, Inc. $32.4608/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233795334 CMS
GlaxoSmithKline, LLC. $24.6707/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190632315 CMS
AstraZeneca Pharmaceuticals LP $24.1107/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206394569 CMS
GENZYME CORPORATION $33.7007/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233419015 CMS
GlaxoSmithKline, LLC. $21.7407/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190637461 CMS
GlaxoSmithKline, LLC. $31.9407/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191382224 CMS
Avadel CNS Pharmaceuticals, LLC $30.6507/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208531587 CMS
Grifols USA, LLC $25.2307/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249568179 CMS
Viatris Specialty LLC $20.5607/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238494615 CMS
GlaxoSmithKline, LLC. $32.3907/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190351480 CMS
Verona Pharma, Inc. $24.5007/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233795358 CMS
Verona Pharma, Inc. $1.7807/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233795360 CMS
HARMONY BIOSCIENCES LLC $40.3806/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222395832 CMS
Verona Pharma, Inc. $34.8806/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233795372 CMS
Electromed, Inc. $3.9206/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224593034 CMS
AstraZeneca Pharmaceuticals LP $23.1606/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206222580 CMS
GlaxoSmithKline, LLC. $30.1306/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190627950 CMS
Lilly USA, LLC $20.6306/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186910214 CMS
GlaxoSmithKline, LLC. $31.3106/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190969006 CMS
Grifols USA, LLC $35.1406/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249568177 CMS
GlaxoSmithKline, LLC. $32.3906/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190880597 CMS
Optinose US, Inc. $13.8806/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1163258934 CMS
Philips North America LLC $14.9306/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232604066 CMS
GENZYME CORPORATION $40.1406/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233418993 CMS
GlaxoSmithKline, LLC. $32.9006/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190662365 CMS
Verona Pharma, Inc. $21.2606/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233795380 CMS
Verona Pharma, Inc. $1.7506/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233795382 CMS
Avadel CNS Pharmaceuticals, LLC $23.0606/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208531585 CMS
JAZZ PHARMACEUTICALS INC. $39.2906/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234314683 CMS
ANI Pharmaceuticals, Inc. $31.8805/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248649170 CMS
GlaxoSmithKline, LLC. $13.3505/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191392327 CMS
Lilly USA, LLC $29.7005/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186860559 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,689.86 93
PY2020 $1,114.10 54
PY2021 $1,052.90 44
PY2022 $2,319.19 80
PY2023 $2,990.15 106
PY2024 $2,739.60 98
PY2025 $3,981.23 168

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $25,164.46 22
PY2024 Principal investigator $62,053.29 55
PY2023 Principal investigator $61,292.45 21
PY2022 Principal investigator $46,508.42 10
PY2021 Principal investigator $19,921.00 9
PY2020 Principal investigator $11,500.00 1
PY2019 Principal investigator $79,086.52 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

22 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $9,986.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744279
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,027.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744281
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $344.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744283
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $200.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744285
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,500.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744287
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $114.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744289
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,895.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744291
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $600.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744293
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $2,479.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744295
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $98.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744297
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $154.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744299
Principal investigator 1 Chiesi USA, Inc. $240.00 06/12/2025 Non-covered Recipient Entity
SOUTHERN CALIFORNIA MEDICAL GROUP INC
A 12 week, randomized, double-blind, multicenter, active controlled, 2-arm parallel group study testing the superiority of CHF 1535 pMDI 800/24?g total daily dose (fixed combination of extrafine beclomethasone dipropionate plus formoterol fumarate) compared to CHF 718 pMDI 800?g total daily dose (extrafine beclomethasone dipropionate) in adults with asthma on medium or high-dose inhaled corticosteroid. No dispute reported 06/30/2026 1234402990
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $0.96 06/11/2025 Non-covered Recipient Entity
So Cal Clinical Research
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744263
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $6.72 06/11/2025 Non-covered Recipient Entity
So Cal Clinical Research
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744265
Principal investigator 1 GlaxoSmithKline, LLC. $2,912.08 04/24/2025 Non-covered Recipient Entity
SOUTHERN CALIFORNIA MEDICAL GROUP
A PROSPECTIVE, REAL-WORLD, INTERVENTIONAL STUDY TO EVALUATE THE EFFECT No dispute reported 06/30/2026 1192121670
Principal investigator 1 GlaxoSmithKline, LLC. $578.70 04/04/2025 Non-covered Recipient Entity
SOUTHERN CALIFORNIA MEDICAL GROUP
A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL No dispute reported 06/30/2026 1192121654
Principal investigator 1 GlaxoSmithKline, LLC. $1,860.00 03/07/2025 Non-covered Recipient Entity
SOUTHERN CALIFORNIA MEDICAL GROUP
A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL No dispute reported 06/30/2026 1192121663
Principal investigator 1 GlaxoSmithKline, LLC. $982.00 02/07/2025 Non-covered Recipient Entity
SOUTHERN CALIFORNIA MEDICAL GROUP
A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL No dispute reported 06/30/2026 1192121659
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $42.00 01/31/2025 Non-covered Recipient Entity
So Cal Clinical Research
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744255
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $35.00 01/31/2025 Non-covered Recipient Entity
So Cal Clinical Research
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744257
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $55.00 01/31/2025 Non-covered Recipient Entity
So Cal Clinical Research
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744259
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $55.00 01/31/2025 Non-covered Recipient Entity
So Cal Clinical Research
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744261